Diabetes Insipidus

• FDA approval · 2024-04-30
  FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Accord Healthcare Inc.)

  The FDA approved a supplemental application for hydrochlorothiazide filed by Accord Healthcare Inc. under ANDA 202556. The document does not…

• FDA approval · 2023-07-21
  FDA Approved: VASOPRESSIN — Supplemental Application (Amneal Pharmaceuticals LLC)

  FDA approves Amneal's supplemental application for Vasopressin under ANDA212944, authorizing changes to the approved generic product.

• FDA approval · 2022-08-05
  FDA Approved: VASOPRESSIN — Original Application (Amneal Pharmaceuticals LLC)

  The FDA approved Amneal Pharmaceuticals LLC's original application for a generic vasopressin product.

• FDA approval · 2022-07-18
  FDA Approved: VASOPRESSIN — Original Application (Amphastar Pharmaceuticals, Inc.)

  FDA approved Amphastar Pharmaceuticals' generic vasopressin product through an Original Application (ANDA). This allows marketing of a vasop…

• FDA approval · 2013-01-25
  FDA Approved: DESMOPRESSIN ACETATE — Original Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved an Abbreviated New Drug Application for Desmopressin Acetate from Sun Pharmaceutical Industries, marking a generic product appr…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2008-03-11
  FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Apotex Corp.)

  FDA approved a supplemental application for Desmopressin Acetate from Apotex Corp., updating the approved generic product. The action formal…